According to a new report by Polaris Market Research, the global multiomics for precision medicine market was valued at USD 1,707.5 million in 2025 and is projected to reach USD 7,014.8 million by 2034, expanding at a CAGR of 17.0% over the forecast period. Growth is underpinned by expanding linked patient cohorts, integrated multiomic workflows, and structured health-data regulation that is opening new pathways for evidence-generation across genomics, proteomics, and clinical datasets.

What Is Driving Multiomics for Precision Medicine Market Growth?

Demand is climbing as large, diverse patient cohorts strengthen the statistical foundation for precision-medicine models, while integrated workflows reduce the operational friction of combining genomic, transcriptomic, and proteomic layers. Biopharma and academic buyers are prioritizing reproducible, validated pipelines, pushing multiomics adoption across oncology and rare-disease research. Polaris analysts note that evidence density, not data volume alone, is emerging as the key commercial differentiator, with consumables emerging as the largest revenue contributor and instruments posting the fastest incremental gains.

Key Trends Shaping the Multiomics for Precision Medicine Industry

Governed Health-Data Reuse Pathways

Regulatory frameworks such as the EU's Regulation 2025/327 are weaving in structured secondary-use provisions, creating pathways for sensitive molecular and clinical data to support broader research use.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/multiomics-for-precision-medicine-market

Single-Cell and Spatial Resolution

Methods that move analysis from averaged tissue samples to individual cells are reflecting a broader shift toward resolving cellular heterogeneity and immune states that bulk measurements obscure.

Treatment-Linked Real-World Datasets

Longitudinal datasets tied to treatment response are reshaping the competitive landscape as vendors bundle instruments, software, and clinical-linkage data into defensible evidence assets.

Market Segmentation: Breaking Down the Multiomics for Precision Medicine Market

Polaris segments the multiomics for precision medicine market by component, omics type, technology, application, end user, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Component

Consumables held the largest share in 2025 at USD 512.1 million, reflecting recurring per-sample reagent and assay spend across every molecular layer. Instruments are projected to grow at the fastest CAGR of 17.72% as continued investment in sequencing, mass spectrometry, and single-cell profiling platforms expands the installed base.

By Omics Type

Genomics led the omics-type segment at USD 693.9 million in 2025, serving as the stable reference layer for inherited and somatic variation. Proteomics is projected to grow at a CAGR of 16.4% as researchers seek functional evidence to complement genomic findings.

By Technology

Bulk multiomics held the largest share at USD 1,053 million in 2025, suited to cohort-scale studies and broad research programs. Spatial multiomics is projected to expand at the fastest CAGR of 17.46%, offering resolution that reveals cellular heterogeneity and tissue context bulk methods can miss.

By Application and End User

Oncology led the application segment at USD 581.4 million in 2025, while rare disease applications are growing at 17.7% CAGR as multiomic evidence helps resolve uncertain genomic variants. Academic and research institutes lead end users at 38.47% share, narrowly ahead of pharmaceutical and biotechnology companies at 36.03%, while hospitals and clinical laboratories are expected to grow at 16.1% CAGR.

Regional Outlook: Where Is Multiomics for Precision Medicine Growing Fastest?

North America held the dominant market share of 41.36% in 2025, supported by large-scale biomedical datasets, established sequencing infrastructure, and strong biopharma activity, with the NIH All of Us program now including more than 535,000 whole genomes linked to nearly 482,000 electronic health records. Asia Pacific is projected to register the fastest CAGR of 17.6% through 2034, driven by expanding sequencing and digital-health infrastructure across China, Japan, Singapore, and India. Europe follows as the second-largest market at USD 477.7 million, developing through a regulation-led model under the European Health Data Space.

Competitive Landscape: Leading Multiomics for Precision Medicine Companies

Key players profiled in the report include Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, QIAGEN N.V., and 10x Genomics, Inc., who are focusing on connected multiomics platforms and clinical-data partnerships to strengthen market position across the consumables and genomics segments outlined above. Recent moves include Roche's May 2026 definitive agreement to acquire PathAI for up to USD 1.05 billion to combine AI-driven digital pathology with its companion-diagnostics and oncology portfolio, and SOPHiA GENETICS' August 2026 global collaboration with AstraZeneca to develop companion diagnostics for precision oncology therapies, both aimed at deepening clinical-grade evidence generation.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching multiomics for precision medicine market entry, this report benchmarks market share, segment-level pricing, and forecast data — by component, omics type, technology, application, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing sequencing and proteomics vendors, investors sizing entry points, and strategy teams tracking spatial multiomics and rare-disease applications as growth adjacencies.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

top-video-game-companies-leading-the-global-market

fiber-optics-market

https://www.polarismarketresearch.com/contact

semiconductor-fabless-market

cell-culture-media-market

extreme-ultraviolet-lithography-market

global-ready-to-drink-tea-and-coffee-market

white-cement-market

top-sports-analytics-companies